Tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate, known by its CAS number 571189-16-7, is a compound of significant interest in the field of pharmaceutical intermediates. NINGBO INNO PHARMCHEM CO.,LTD. provides this essential chemical, which plays a critical role in the synthesis of advanced pharmaceutical products. As a reputable supplier in China, we focus on delivering chemicals that meet exacting standards for research and development, as well as commercial production.

The chemical properties of Tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate are well-defined, contributing to its utility in complex organic synthesis. Its purity, typically u226598.0% (HPLC), is a testament to the rigorous manufacturing processes employed. This high level of purity is crucial for pharmaceutical applications, where even trace impurities can affect the efficacy and safety of the final drug. The compound's physical characteristics, such as its appearance as an off-white to orange crystal or powder, are also important for identification and quality control.

The primary application for this intermediate lies in its use for the synthesis of Palbociclib, a targeted therapy for breast cancer. This makes it a key component in the pharmaceutical R&D supply chain. Pharmaceutical companies seeking reliable organic synthesis materials can depend on NINGBO INNO PHARMCHEM CO.,LTD. for a consistent supply of this intermediate. Our expertise as a manufacturer in China ensures that we can meet the demands of the global market for high-quality pharmaceutical building blocks.

In the broader context of fine chemicals, Tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate exemplifies the precision and complexity involved in chemical manufacturing. Its availability supports the development of innovative treatments, underscoring the importance of specialized chemical suppliers in advancing healthcare. The careful handling and storage of this compound are also critical to maintaining its integrity, ensuring it performs optimally in subsequent synthetic steps.